may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
.
. (image: rex/shutterstock)
.
.
.
.
.
.
.
.
"as soon as she saw him," said tamara nunley, r.n., "you could see her perk up."
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
.
.
. 
.
.